Sequana Medical NV (STU:2SE) Cash-to-Debt : 0.19 (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Sequana Medical NV Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Sequana Medical NV's cash to debt ratio for the quarter that ended in Jun. 2024 was 0.19.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Sequana Medical NV couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2024.

The historical rank and industry rank for Sequana Medical NV's Cash-to-Debt or its related term are showing as below:

STU:2SE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09 Med: 1.19 Max: No Debt
Current: 0.19

During the past 10 years, Sequana Medical NV's highest Cash to Debt Ratio was No Debt. The lowest was 0.09. And the median was 1.19.

STU:2SE's Cash-to-Debt is ranked worse than
84.87% of 859 companies
in the Medical Devices & Instruments industry
Industry Median: 1.65 vs STU:2SE: 0.19

Sequana Medical NV Cash-to-Debt Historical Data

The historical data trend for Sequana Medical NV's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Sequana Medical NV Cash-to-Debt Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

1.73

1.40

1.19

1.07

0.15

Sequana Medical NV Semi-Annual Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash-to-Debt	Get a 7-Day Free Trial											2.75	1.07	0.97	0.15	0.19

Competitive Comparison of Sequana Medical NV's Cash-to-Debt

For the Medical Devices subindustry, Sequana Medical NV's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sequana Medical NV's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Sequana Medical NV's Cash-to-Debt falls into.

Sequana Medical NV Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Sequana Medical NV's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.584	/	(8.087	+	9.433)
	=	0.15

Sequana Medical NV's Cash to Debt Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4.153	/	(10.078	+	12.255)
	=	0.19

Sequana Medical NV (STU:2SE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Sequana Medical NV Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (STU:2SE) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

SEQUA:Belgium

Address

Kortrijksesteenweg 1112, bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV Headlines

No Headlines